問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
葉馨喬
下載
2025-10-01 - 2031-04-30
Condition/Disease
Patients with hereditary transthyretin transporter amyloid polyneuropathy (hATTR-PN)
Test Drug
Nucresiran (ALN-TTRSC04) vutrisiran (ALN-TTRSC02)
Participate Sites3Sites
Recruiting3Sites
2023-01-01 - 2025-12-31
Participate Sites1Sites
Recruiting1Sites
2025-01-03 - 2028-12-31
2022-02-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2023-05-01 - 2027-06-24
Participate Sites12Sites
Recruiting12Sites
2021-12-01 - 2026-09-30
2022-04-01 - 2025-09-30
Participate Sites7Sites
Not yet recruiting2Sites
Terminated2Sites
2021-05-18 - 2027-04-09
Recruiting7Sites
2023-01-16 - 2025-08-30
Participate Sites23Sites
Recruiting13Sites
Terminated5Sites
2019-06-01 - 2023-05-31
全部
